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indicator bacteria or a single strain with
multiple markers are therefore necessary to
overcome the effects of mutagen specificity.
Since the bacteria used in short-term tests
lack the enzymesystems, presentinmammals,
which are responsible for the metabolism of
xenobiotics to species which are more easily
excreted (and, unfortunately in some cases
converted to highly reactive electrophilic
inetabolites capable of damaging DNA)
tissue extracts must be added to mimic
mammalian metabolism in the chosen assay
system. Such metabolizing systems are, of
course, very crude. Their activity can be
modulated in arbitrary ways by pretreatment
of the donor animals with a variety of com-
pounds which can vary both the level and
nature of the metabolizing systems. Further
variability can be imposed by the choice of
donor species and strain, the age ofthe chosen
animals, and changing the proportion of
tissue extract relative to co-factors, and by
the method used in the assay (e.g. liquid
incubation vs agar overlay).
It is clear, therefore, that there is scope for
enormous variety in bacterial mutation tests,
depending on the choice offorward or reverse
mutation, bacterial species and strain, and
by the nature and activity of the metabolic
system. Taking into account these variables,
it seems very unlikely that a quantitative
relationship between mutagenic potency and
carcinogenic potency would exist for the
generality of known chemical carcinogens
tested in a highly selective assay system; the
gross imperfections of long-term carcino-
genicity tests in animals, especially in sensi-
tivity and (in many cases) in the reporting of
data, are further factors which militate
against the likelihood of useful quantitative
extrapolations between bacterial mutation
data and carcinogenic risk to mammals
including man. Recently published studies
which have addressed this problem directly,
using closely related homologous chemical
series, have failed to demonstrate such a
quantitative relationship.
On the other hand, there is now a plethora
ofinformation, based on numerous large scale
trials, which reinforces the view that bac-
terial mutagenicity tests, if performed with
due regard to the scientific criteria of repro-
ducibility, statistical significance and dose-.
responsiveness, are extremely useful for
determining whether a chemical has qualities
characteristic of carcinogens. Moreover, the
speed and sensitivity of these tests allows
their use in a variety ofroles other than mass-
screening; the analysis of complex mixtures
from biological fluids, excreta, air and water
samples, goods, cosmetics and products from
industrial processes is now quite feasible by
the application of appropriate bacterial
mutation assays.
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LONG-TERM animal carcinogenicity tests
are unable to keep up with the number of
chemicals requiring testing. A variety of
short-term tests have been proposed which
are alleged to be capable of discriminating
between carcinogens and non-carcinogens.
Until the mechanism of cancer induction and
progression is established, short-term tests
to detect carcinogens must be based on
empirical correlations between animal and
human cancer and the end-points ofthe tests.
There are several theories on the cause of
cancer but most are genetically based, since
tumours are due to an irreversible process and
result in new information being passed to
subsequent cell generations. The majority of
short-term tests to detect carcinogens are
based on the idea that the primary event in
chemical carcinogenesis is mutation in soma-
tic cells. While data gleaned from the use of
these tests have provided strong evidence
that many chemical carcinogens are mutagens
and that the initial event in chemical muta-
genesis is an attack on DNA by electrophiles,
there are, nevertheless, some chemicals whose
carcinogenic action cannot be explained in
this way, e.g. promoters, hormonal carcino-
gens and solid-state carcinogens.504 BRITISH ASSOCIATION FOR CANCER RESEARCH
The short-term tests to detect carcinogens
can be grouped as follows:
1. Those that can be used to determine
carcinogenic potential.
(a) Microbial mutation tests which include
auxiliary metabolism of the test com-
pound by a fraction of mammalian
liver homogenate.
(i) Bacterial forward and reverse
mutation;
(ii) Yeast and fungal mutation, gene
conversion, mitotic recombination
or non-disjunction;
(iii) DNA damage and repair including
chromosome damage;
(iv) Mammalian cell mutation; and
(v) Mammalian cell transformation.
(b) Non-mutation-based tests.
(i) Mouse skin sebaceous gland sup-
pression;
(ii) Degranulation of the rough endo-
plasmic reticulum of rat liver cell.
2. Whole-mammal tests which can aid in
assessing carcinogenic hazard when con-
ventional carcinogen testing data in ani-
mals are absent.
(i) DNA binding oflabelled chemical;
(ii) Host-mediated assays where micro-
organisms are used to test the
mutagenicity of a chemical after
parenteral application;
(iii) Sperm morphology;
(iv) Mammalian hair spot test (after
treatment in utero);
(v) Dominant-lethal test in mice;
(vi) Heritable-translocation test in mice;
(vii) Biochemical detection of somatic
cell mutation; and
(viii) In vivo cytogenetics in somatic and
germ cells.
Structure/activity
In addition to the above testing procedures
a consideration of the relation between
structure and activity is essential if indis-
criminate and wasteful screening is to be
avoided. The precision of a test can be
improved by the selection of an appropriate
chemical-class control compound. Knowledge
of the metabolism of a group of compounds
and the responses given by the chemicals to
a variety ofshort-term tests is valuable when
the most effective assay is to be selected and
when test results are interpreted.
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THE THEORY of two-stage carcinogenesis
involving initiation and promotion was
developed by Berenblum (Berenblum, 1974)
and the experimental data on carcinogenesis
in mouse skin which he and his colleagues
produced in the 1940s and 1950s still provide
the factual basis which underpins current
concepts ofmulti-stage carcinogenesis. Multi-
stage models in which the promoting phase
is further divided into two or more stages are
required to explain the epidemiological data
on time-related tumour incidence in man, and
they also apply to experimental carcino-
genesis both in skin and other organs, in-
cluding the liver and bladder.
Multi-stage carcinogenesis in the bladder
involves first a permanent transformation of
cells in the transitional epithelium (uro-
thelium) into latent tumour cells by a thres-
hold or sub-threshold dose of a bladder
carcinogen such as N-methyl-N-nitrosourea
(MNU) N-butyl-N-(4-hydroxybutyl) nitro-
samine (BBN) or N-(4-(5-nitro-2-furyl)-2-
thiazolyl) formamide (FANFT). The initiated
cells may then be converted into tumour
cells by further exposure to the same or
another carcinogen which is organotropic for
the urothelium, or by prolonged application
of a promoter which itselfis not effective as a
complete (initiating+promoting) carcinogen.
In the bladder, saccharin, cyclamate, trypto-
phan and cyclophosphamide all behave
predominantly as promoters. Development of
a visible growing tumour from the promoted